<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="4" ids="30413">Heme</z:chebi> oxygenase-1 (HO-1) is a stress-induced enzyme that catalyses the oxidation of <z:chebi fb="4" ids="30413">heme</z:chebi> to <z:chebi fb="0" ids="17033">biliverdin</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The primary deficiency of this enzyme has been shown in HO-1 knockout mice, and is characterized by intrauterine <z:hpo ids='HP_0011420'>death</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The first case of human HO-1 deficiency was reported in 1999 </plain></SENT>
<SENT sid="3" pm="."><plain>Human HO-1 deficiency has been observed to involve the endothelial cells more severely, resulting in <z:mp ids='MP_0010163'>hemolysis</z:mp> and <z:hpo ids='HP_0005521'>disseminated intravascular coagulation</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We report another case of human HO-1 deficiency in a young girl with congenital <z:hpo ids='HP_0001746'>asplenia</z:hpo>, who presented with severe <z:mp ids='MP_0010163'>hemolysis</z:mp>, <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:hpo ids='HP_0000123'>nephritis</z:hpo>, which was refractory to therapy with <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, and rituximab </plain></SENT>
</text></document>